Iovance Biotherapeutics
IOVA
#3883
Rank
A$4.82 B
Marketcap
A$10.42
Share price
-5.61%
Change (1 day)
197.49%
Change (1 year)

EPS for Iovance Biotherapeutics (IOVA)

EPS in 2026 (TTM): A-$0.77

According to Iovance Biotherapeutics 's latest financial reports the company's current EPS (TTM) is A-$0.80. In 2025 the company made an earnings per share (EPS) of A-$1.69 an increase over its 2024 EPS that were of A-$1.96.

EPS history for Iovance Biotherapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.77-54.23%
2025A-$1.69-13.85%
2024A-$1.96
2022A-$3.7511.71%
2021A-$3.35
2019A-$2.3923.44%
2018A-$1.93-9.22%
2017A-$2.13-20.34%
2016A-$2.67176.56%
2015A-$0.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
A-$0.09065-88.68% Bahamas
NRC Health
NRC
A$0.44-154.72%๐Ÿ‡บ๐Ÿ‡ธ USA